Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 53.54

-3.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who started this subject	6/11/2002 8:31:06 PM
From: A.J. Mullen	Read Replies (1) of 52153

I'm surprised there has been no discussion of Genentech: siliconinvestor.com They were sued for fiddling the books, defrauding a much smaller company. Reminiscent of Igen. I once asked a friend, who's a director of a big pharmaceutical company, "how can a company know whether or not a process it has licenses was used by another comp[any. His response was " a company like xxx lives by its intellectual property, it's just not part of our culture. And if a company suspects something, they have the right to look at lab-books etc." He might be right about his company, but Hoff. La Roche v. Igen, and now Genentech suggest it's areal problem. Ashley

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next